Blood test may predict radiation damage risk
NCT ID NCT00893035
First seen Feb 05, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study looked at whether a simple blood test can predict which patients are more likely to have long-term side effects from radiation therapy. Researchers measured how well certain immune cells (CD8 T-cells) die after being exposed to radiation. The goal was to see if this test could help doctors personalize treatment to avoid severe complications. The study involved 885 people with breast or prostate cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CRLC Val d'Aurelle
Montpellier, 34000, France
Conditions
Explore the condition pages connected to this study.